Treatment with Bivalirudin (Hirulog) as Compared with Heparin during Coronary Angioplasty for Unstable or Postinfarction Angina
John A. Bittl(Brigham and Women's Hospital), Burt Adelman(Massachusetts General Hospital), Ezra Deutsch(Temple University), Bernard Chaitman(Saint Louis University), John Strony(Merck & Co., Inc., Rahway, NJ, USA (United States)), John M. Maraganore(Biogen (United States)), Waqar Ahmed(Brigham and Women's Hospital), Jeffrey Brinker(Johns Hopkins Hospital), Clyde R. Meckel(Brigham and Women's Hospital)
Cited by 496
Related Papers
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2012|2k
ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary
|Journal of the American College of Cardiology|2002|1.7k
Liberal or Restrictive Transfusion in High-Risk Patients after Hip Surgery
|New England Journal of Medicine|2011|1.3k
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
|New England Journal of Medicine|2012|941
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|753